Correlation Between Aquestive Therapeutics and 747262AU7
Specify exactly 2 symbols:
By analyzing existing cross correlation between Aquestive Therapeutics and QVC 445 percent, you can compare the effects of market volatilities on Aquestive Therapeutics and 747262AU7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of 747262AU7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and 747262AU7.
Diversification Opportunities for Aquestive Therapeutics and 747262AU7
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Aquestive and 747262AU7 is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and QVC 445 percent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on QVC 445 percent and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with 747262AU7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of QVC 445 percent has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and 747262AU7 go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and 747262AU7
Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the 747262AU7. In addition to that, Aquestive Therapeutics is 4.56 times more volatile than QVC 445 percent. It trades about -0.06 of its total potential returns per unit of risk. QVC 445 percent is currently generating about -0.2 per unit of volatility. If you would invest 9,923 in QVC 445 percent on September 1, 2024 and sell it today you would lose (433.00) from holding QVC 445 percent or give up 4.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. QVC 445 percent
Performance |
| Timeline |
| Aquestive Therapeutics |
| QVC 445 percent |
Aquestive Therapeutics and 747262AU7 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and 747262AU7
The main advantage of trading using opposite Aquestive Therapeutics and 747262AU7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, 747262AU7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 747262AU7 will offset losses from the drop in 747262AU7's long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
| 747262AU7 vs. AEP TEX INC | 747262AU7 vs. US BANK NATIONAL | 747262AU7 vs. FactSet Research Systems | 747262AU7 vs. Golden Agri Resources |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |